Home Overview Press Room Blog Publications For Students about us
Search

About the States' Policies & Human Biotechnology


Individual states are filling the regulatory void created by the federal government’s failure to provide comprehensive legislation governing human biotechnologies. This is creating an often inconsistent policy patchwork.

California

State action is evident in a number of areas, including embryonic stem cell, cloning, egg retrieval, and assisted reproduction. More than a dozen states have laws banning reproductive cloning, about half of which also prohibit cloning for stem cell research. Dozens of similar bills are introduced in other states each year.

In response to President Bush’s restrictions on the federal funding of human embryonic stem cell research, several states initiated their own funded research programs. California led the way in 2004 with Proposition 71, which set aside $3 billion of public funds for stem cell research over ten years.



DIY sperm test to hit the market this fallby Meghana KeshavanSTAT NewsJune 20th, 2016The semen centrifuge called Trak will calculate sperm count but not sperm motility or other factors that affect fertility.
Do women who donate their eggs run a health risk?by Sandra G. BoodmanThe Washington PostJune 20th, 2016People who make egg donations may feel exploited during the process and experience serious health consequences due to a dearth of research on the effects of egg retrieval.
Start-ups selling new blood tests directly to consumers raise safety and accuracy concerns by Melody PetersenThe Los Angeles TimesJune 19th, 2016The biotech start-ups often seek to make the medical lab business more accessible but frequently distribute incorrect results, harming individuals.
Genetically enhancing our children could raise interest ratesby James D. MillerBusiness InsiderJune 19th, 2016Should researchers develop technology to genetically decipher and alter intelligence, individuals and the state would borrow more and save less.
Did Infamous Tuskegee Study Cause Lasting Mistrust of Doctors Among Blacks?by Aaron E. CarrollThe New York TimesJune 17th, 2016The Tuskegee Study was a horrific instance of racism and injustice in medical research, but racism is a systemic condition of US health care, not an isolated event.
Stem cell factory opens door for trials of personalized diabetes treatment by Andrew JosephStat NewsJune 16th, 2016The iPS cell treatment for Type I diabetes could enter the clinical trials phase in a few years.
How iPS cells changed the worldby Megan ScudellariNatureJune 15th, 2016Induced pluripotent stem cells have become a potentially helpful method of personalized therapy.
Should We Sequence the DNA of Every Cancer Patient?by Antonio RegaladoMIT Technology ReviewJune 14th, 2016To match cancer patients with drugs, Strata Oncology plans to offer free genetic tests.
The Politics of Women’s Eggsby Diane ToberUndarkJune 10th, 2016Scientists are eager to pay women for their eggs, but they are less interested in understanding the long-term health impacts of egg donation.
Genetically engineered bugs to fight malaria and Zika? Not so fast, experts sayby Joel AchenbachThe Washington PostJune 8th, 2016The use of "gene drive" technologies threaten incalculable harm to ecosystems worldwide.
Displaying 1-10 of 450  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760